The Analyst Verdict: United Therapeutics In The Eyes Of 8 Experts
The Analyst Verdict: United Therapeutics In The Eyes Of 8 Experts
分析師評價：美國聯合醫療在8位專家眼中的表現
A comprehensive examination of how financial...In the last three months, 8 analysts have published ratings on United Therapeutics (NASDAQ:UTHR), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中，8名分析師已經就美國聯合醫療（納斯達克：UTHR）發表了評級，提供了從看好到看淡的多樣化觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $356.38, a high estimate of $400.00, and a low estimate of $280.00. Observing a 11.46% increase, the current average has risen from the previous average price target of $319.75.
分析師所分析的12個月價格目標提供了一些見解，平均目標爲356.38美元，高估爲400.00美元，低估爲280.00美元。當前的平均價位較上一個平均價格目標的319.75美元上漲11.46%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
A comprehensive examination of how financial...
對金融專家如...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間